Introduction
Following primary immunization with a T-dependent antigen, rational explanation for the finding, made in several laboratories, that the primary antibody responses and the anamnestic antibody-forming cells and memory B cells evolve in different compartments of lymphatic tissues (1) , and perhaps from response are dominated by different clonotypes (4) (5) (6) (7) (8) . This scenario also predicts that the repertoire of memory antibody separate precursor cell lineages (2) . The antibody-secreting plasmacytes, which produce the bulk of primary antibody, response reflects that of the GC B cells (9) (10) (11) ; however, this proposal deserves further scrutiny. differentiate from B cells in the T cell-rich areas of periarteriolar lymphatic sheaths, whereas memory B cells originate in
The repertoire of progenitor memory B cells has been studied extensively in splenic GC during the primary response germinal centers (GC) that form transiently after the immunization (1) . It is now widely accepted that the GC B cells, which to a hapten, (4-hydroxy-3-nitrophenyl)acetyl (NP), in mice with IgH b allotype. The heavy chain V regions (V H ) of NP-binding Ig undergo rounds of somatic hypermutations in their rearranged BCR genes followed by affinity-based selection, are progenmolecules in these animals are encoded by several germline segments of the V186.2/V3 subfamily of the J558 family itors of both cells that produce antibody with increasing affinity during the advancement of immune response and the memory (12) (13) (14) (15) (16) (17) . The repertoire of NP-reactive GC B cells can be summarized as follows: B cells that give rise to the rapid anamnestic antibody response upon antigen recall (3) . This model provides a
(1) The majority of expressed BCR are encoded by V H 186.2/ DFL16.1/J H 2 rearrangements (10, (18) (19) (20) with canonical fusion and hybridoma selection or FACS that may introduce a sampling bias. Using this approach, we aimed to analyze Tyr95 that is considered critical for NP binding (10) . (2) In most studies (18,20), but not all (10) , the CDR3 appear the repertoire of memory effector cells in comparison with GC lineage cells that produce high-affinity antibody during the to have little junctional diversity. ( 3) The V186.2 ϩ GC B accumulate somatic point mutations advancement of primary response. Furthermore, memory responses were examined not only in the spleen, but also in to an average of 3-5 mutations/V H (10, (18) (19) (20) . This includes a recurrent point mutation in V H position 33 that bone marrow (BM), because the latter is a major site of rapid anamnestic responses (27) (28) (29) . The antigen boost may have replaces Trp (W) with Leu (L) in a majority of recovered cells (10, 19) . This mutation alone increases the affinity of initiated a rapid migration of activated memory cells from peripheral lymphatics to BM, where they differentiate into V186.2-DFL16.1-J H 2(V λ 1) antibody for binding to NP by 10-fold (21) indicating a selection of GC B cells into the plasmacytes (29). Another hypothesis is that BM may be colonized by memory B cells and/or their progenitors which higher-affinity memory cell population. (4) In addition to the V186.2 clonotypes, the NP-specific GC give rise to antibody-forming cells in situ after secondary immunization (27, 28) . The latter scenario is consistent with contained a variable portion of B cells expressing other V H segments of the V186.2/V3 gene family, such as the observation that GC B cells home to BM upon adoptive transfer into naive recipients (30) . Finally, the question arises V102, V23, VC1H4, V165.1, CH10, V3, V24. 8 and V593 (17,19,20 limpet hemocyanin, chicken γ-globulin (CGG) (both from rearrangements in which the nucleic acid deletions at the DJ Sigma, St Louis, MO) or BSA (Amersham Life Science, boundary were more extensive (14,16) compared to those in Cleveland, OH) as described (31). Mice were immunized with the GC B cells (10, (18) (19) (20) . This repertoire pattern suggests a single i.p. injection of 10 µg of an antigen in alum and that precursors of memory B cells represented only a small challenged with 10 µg of a soluble antigen in PBS, i.p. fraction of the GC cell population. However, these studies used complicated experimental designs that could bias the T cell depletion in in vivo results. The secondary responses were elicited respectively Anti-CD4 mAb GK1.5 (ATCC, Rockville, MD) was produced in mice treated neonatally with an anti-idiotypic antibody (16) as ascitic fluid and the IgG was purified on a HiTrap Protein and in a single mouse that received two consecutive antigen G column (Amersham Pharmacia Biotech, Piscataway, NJ). boosts within 3 weeks after the priming (14). In contrast, Mice were injected i. APFC assay that are readily identified in lymphocyte suspension ex vivo, using a modified antibody plaque-forming cell (APFC) assay Lymphocytes producing the NP-specific IgG antibody were detected with a modified hemolytic plaque assay (26) using (26). The rearranged Ig genes from individual APFC can be amplified and sequenced without the need for either cell sheep red blood cells coupled with hapten. Antibodies pro- duced early in the response to NP bind more avidly to NIP, binding activity to both NP-BSA and NIP-BSA. Hybridomas were cloned by limiting cell dilution at 0.3 cell/well and the whereas the secondary antibodies bind to NP and NIP with positive clones were expanded. mAb were purified from similar affinities (32, 33) . In order to capture cells producing culture supernatants using Protein A-Sepharose columns both types of antibody molecules, we performed the plaque (Pharmacia Biotech, Uppsala, Sweden); their H chain and assay with sheep red blood cells conjugated to NIP. Petri L chain isotypes were determined by standard ELISA with dishes (10 cm diameter) were pre-coated with 5 ml of 0.5% NP-BSA and NIP-BSA as antigens in solid phase. The plates agarose (Gibco, Grand Island, NY). A mixture containing were probed with goat anti-mouse Ig isotype-specific anti-2.5 ml of 0.3% agarose in Basal Medium Eagle (Gibco) kept bodies, and anti-κ and anti-λ chain antibodies (all from in a 46°C waterbath, 100 µl of lymphocyte suspension and Southern Biotechnology Associates). The VDJ segments from 100 µl of NIP-red blood cells, with or without 25 µl of the clones were characterized by PCR amplification and antibody mixture containing goat anti-mouse IgM (Southern sequencing as described below. Biotechnology Associates, Birmingham, AL) and rabbit anti-
The affinities of mAb were estimated in two ways. Their mouse IgG (Sigma), was poured on the solid agarose base K a values for NP and NIP haptens were measured by and the dishes were incubated at 37°C/5% CO 2 for 2 h. The fluorescence quenching in a Shimadzu RF-5301 fluoroplates were then covered with 3 ml of diluted guinea pig spectrophotometer using monovalent haptens NP-and complement (Gibco) and incubated for an additional 2 h to NIP-aminocaproric acid (Cambridge Research) as described make the hemolytic plaques visible. The hemolytic plaque (35, 36) . Relative affinities were also determined by the binding assay readily detects the IgM-producing cells; however, the of mAb to NP-BSA conjugates substituted with different IgG-producing cells can be detected with an optimal concenamounts of haptenic groups (37) . Purified mAb at concentratration of exogenous anti-IgG antibody (26). Our assay was tions from 0.3 l to 3 µg/ml were tested by ELISA for binding calibrated for the detection of IgG using stable cells lines B1-to NP 3 -BSA and NP 18 -BSA. Increasing ratio of binding calcu-8 (34) and B1-8γ1 (35) that produce anti-NP antibody of IgM lated as OD 450 NP 3 -BSA/OD 450 NP 18 -BSA was indicative of and IgG1 isotype respectively. The agarose plates contained increasing affinity of mAb to NP. A similar ELISA protocol was a mixture of anti-mouse Ig antibodies that inhibited the IgMused to determine the heteroclicity of the NP-induced mAb, producing cells and facilitated the IgG producers (Table 1) .
i.e. their preferential binding to NIP (32) . The mAb were For enumeration of APFC, 8-20ϫ10 5 cells were plated per allowed to react with NP 18 -BSA and NIP 24 -BSA and the dish in duplicate. For the isolation of a single APFC, the binding reaction ϭ OD 450 NIP/OD 450 NP was calculated. Ratios cell suspension was highly diluted in order to increase the~1 .0 indicate a lack of heteroclitic reactivity. probability of sampling one cell. We plated 1ϫ10 4 
splenocytes
Recovery and molecular analysis of GC B cells (estimated to be 5ϫ10 3 B cells) and 3-4ϫ10 4 BM cells Spleens were removed from mice on days 12 after primary (estimated as 3-4ϫ10 3 B cells), which yielded ഛ1 plaque immunization, frozen sections were prepared for immunohistoper dish. The center of each plaque, containing a cell clearly chemistry, and NP-reactive GC B cells were identified by dual visible under a dissecting microscope, was aspirated in a staining with peanut agglutinin and NIP-BSA as previously volume of~0.4 mm 3 of agarose. From the total number of described (38) . Cells (~100) from individual GC were microcells plated in 2.5 ml volume, we calculate that each sample dissected (20,38) and transferred into microcentrifuge tubes contained approximately one B cell. On average, 30-60% of for PCR DNA amplification. The first-round PCR product samples yielded a PCR product using the specific primers was re-amplified with the nested primers shown below, with (see below). In contrast, no products were obtained from additional recognition sequences for restriction enzymes (17). random sampling of the red blood cells lawn.
The PCR product was digested with the restriction enzymes, ligated to a plasmid, cloned in competent Escherichia coli Hybridomas and affinity measurements and sequenced as described previously (17). Spleen cells were harvested from mice at day 4 after the Amplification and sequencing of VDJ DNA recovered from secondary challenge with NP-CGG and fused with an SP2/0 individual APFC myeloma cell line (ATCC), using polyethylene glycol (average mol. wt 1450) (Sigma) according to standard procedures.
The individual NIP ϩ , IgG APFC were picked using 50-µl disposable micropipettes (Fisher Scientific, Pittsburgh, PA) Supernatants from fusion wells were screened by ELISA for and transferred into a 0.2 ml microcentrifuge tube with 2.5 µl of 10ϫPCR buffer, 0.5 µl of 20 mg/ml proteinase K (Boehringer Mannheim, Mannheim, Germany), 0.5 µl of 5% Tween 20 and 21.5 µl of dH 2 O. The tubes were incubated at 56°C for 1 h and the proteinase K was then inactivated at 96°C for 10 min. DNA amplification was carried out by two rounds of PCR using pairs of nested primers. The initial round of amplification used primers 5Ј-CCTGACCCAGATGTCCCTTCTTCTCCAGC-AGG-3Ј and 5Ј-GGGTCTAGAGGTGTCCCTAGTCCTTCAT-GACC-3Ј, corresponding to the V186.2 genomic DNA 5Ј transcription start site sequence and to the intron J H 2 sequence respectively. Using the Expand High Fidelity PCR kit (Boehringer Mannheim), the crude cell lysate was mixed in a 50 µl reaction volume with 350 µM dNTP, 0.4 µM of each primer and 1.0 µl of Expand High Fidelity polymerase. It was then amplified by one cycle of 95°C 2 min/55°C 4 min/72°C 2 min and then 40 cycles of 95°C 1 min/55°C 1 min/72°C 2 min in a GeneAmp 2400 PCR System (Perkin Elmer). Reaction Results was electrophoresed on a 1% agarose gel for identification of amplified DNA (~350 bp fragment). The PCR product, Distinctive repertoires of late APFC in the spleen and bone isolated with the QIAquick gel extraction kit (Qiagen, Hilden, marrow Germany), was directly sequenced by the Biopolymer Labor-
The kinetics of appearance of hapten-specific, IgG-producing atory of the University of Maryland School of Medicine using APFC in the spleen and bone marrow in mice immunized an automatic DNA sequencing system (Applied Biosynthesis).
systematically (i.p.) with NP-CGG in alum is shown in Fig. 1 . DNA codons are numbered according to Kabat et al. (39) .
This pattern of antibody-producing cells is familiar from several recent studies (40) (41) (42) . The splenic APFC reached the peak Assignment of DNA sequences to germline V H genes at days 7-10 after the immunization and then declined to a Germline sequences of individual V H segments of V186.2/V3 low, steady level between days 35 and 65. In contrast, specific gene family differ from one another by 2-30 nucleotide APFC did not appear in bone marrow until the second week residues (22) . The APFC that utilized V segments 102, 23, after priming and their number increased through the 2-month C1H4, 165.1, CH10, 3, 593.3, 24.8 and 671.5 contained few, period of observation (Fig. 1) . Cells persisting in the spleen if any, somatic mutations (see Results), and, therefore, the and bone marrow for 2 months after the immunization will be sequences were easily matched to their respective germline referred to as 'late' APFC. counterparts. In contrast, the sequences representing the VDJ rearrangements in a small sample of early splenic V186.2 gene differed from their presumptive germline counter-APFC (day 7) involved predominately the V186.2 segment part by up to 20 nucleotides indicating that the V segments without somatic mutations (Table 2) . At the later stage of the were either somatically mutated or that they were derived response (days 35-65), about half of the splenic APFC used from a different germline gene. Distinction was possible the V186.2 gene and the remaining cells expressed nine because the nucleotide differences between the recovered different analogue genes that were evenly represented sequences and the V186.2 germline sequence typically fell ( (Table 2 ). In a sample that was comprised of 12 distinct point mutation AAG → AGG, whereas the third germline G clonotypes from six animals ( Table 2 , footnote), it was found residue was never changed. These patterns allowed an that 90% of V186.2 ϩ APFC were mutated with an average of 8.5 mutations/V gene, which is nearly a 3-fold increase over unambiguous classification of V186.2 mutants. the mutation frequency found either in GC B cells or in from T h -depleted mice was comparable to the control group in respect to the dominance of V186.2 gene rearrangements, late splenic APFC. The dramatic difference between the distribution of mutations among the V186.2 ϩ APFC in the prevalence of W33L replacement and high ratios of R/S mutations in CDR1 ϩ 2; however, the average frequency of spleen and those in the bone marrow is shown in Fig. 2(a) . Most of the V186.2 ϩ APFC mutants in the spleen and BM mutations/V H was reduced by half, to the levels found in GC B cells. Indeed, the T h cell depletion selectively decreased carried the W33L and used the canonical CDR3 with Tyr95 (see Figs 6a and 7a), which affirms their relatedness to the BM APFC with Ͼ7 mutations/V H , whereas the cells with 1-6 mutations/V H were equally frequent in both T h -depleted and GC B cell lineage, yet the APFC in BM accumulated more somatic mutations.
control animals (Fig. 4) . Despite the high mutation frequency in the V186.2 ϩ cells, Repertoire shift in V186.2 ϩ memory APFC the BM APFC expressing the analogue V H genes were either unmutated or contained only 1-3 mutations/gene ( Table 2, Next we examined whether the repertoire detected in an anamnestic response to NP is similar to that of GC memory V102 and V23), a frequency comparable to that of GC B cells and the late splenic APFC. Thus the high number of mutations B cells and their late APFC progeny. Cohorts of mice were challenged with 10 µg of soluble NP-CGG on days 35 and in BM APFC is peculiar to the dominant V186.2 clonotype.
65 after the priming, and NP-specific IgG APFC were sampled Somatic repertoire of late APFC in BM is T cell dependent 4 days after the boost (Fig. 1) . The data from both animal groups (days 35 and 65) are presented together because Inasmuch as somatic hypermutation is driven by T h cells (43, 44) , it was of interest whether the appearance of the their anamnestic responses were comparable. Eighty percent of secondary APFC expressed the V186.2 gene while the highly mutated BM APFC was T cell dependent. CD4 ϩ lymphocytes were depleted with repeated injections of antiremaining 20% used various analogue V H genes (Table 4) . Somatic mutations were found in all V186.2 ϩ cells in both CD4 mAb GK1.5 beginning on days 18 after the immunization with NP-CGG, i.e. at the time of diminishing GC reaction spleen and BM, with an average of 11 mutations/V H (Table 4 , see the footnote for details on sampling). In contrast to the (42, 45) . The treatment reduced the numbers of CD3 ϩ CD4 ϩ lymphocytes to Ͻ0.1% in both spleen and BM until days 35, late primary APFC, there was no difference in the distribution of mutations among the secondary APFC in the two anatomic when they slowly begun to rise (Fig. 3) . As shown in Table 3 , the repertoire of the late NP-specific IgG APFC in the BM sites (Fig. 2b) . To our surprise the secondary APFC population was dominated by a clonotype that has been rarely detected replaced lysine (K) with arginine (R) in CDR2 position 58 in up to 80% of cells (Figs. 5 and 6 ). Remarkably, the K58R before in the GC B cell lineage. Typical NP-reactive V186.2 ϩ B cells that emerge from the primary GC have the W33L mutants always carried Gly95, which joined the V186.2 gene replacement (10, 19) , and this motif is also found in~70% of late primary APFC in both spleen and BM (Figs 5 and 6 ). Among the memory APFC, however, this mutation declined to~30% while a new recurrent mutation appeared that to either DFL16-1 or DSP2-5/7 segments (Fig. 7) . The use of binding antibody molecule that preclude the co-existence of both mutations in V186.2, or that the two clonotypes, Leu33/ Gly95 instead of Tyr95 must have developed from junctional diversity during V-D-J rearrangements. The V186.2 sequence Tyr95 and Arg58/Gly95, represent two separate pathways of memory maturation and selection. contains a mutational hot-spot consensus motif AAGTA (46, 47) in position 58-59; however, that position 58 mutation is always Repertoire of analogue V H genes in memory anti-NP response. A → G (Fig. 6) argues for antigen selection of the mutated cells. Thus the patterns of recurrent mutations and VD juncVarious analogue VDJ rearrangements were found in the secondary APFC in the spleen as well as in BM but unlike tions identify two functionally distinct populations of V186.2 ϩ memory B cells: (i) Leu33/Tyr95 (Lys58) GC B cells and the heavily mutated V186.2 genes, the analogue V H segments still contained only 1-3 mutations/V H (Table 4) , which represprogenitors of late APFC, and (ii) Arg58/Gly95 (Trp33) progenitors of anamnestic APFC.
ents no increase over the average mutations in GC B cells We noted with interest that, without exception, the W33L and K58R mutations in V186.2 were exclusive of one another among 70 APFC analyzed in this study (Fig. 6) . We speculate that there are either structural constraints imposed on the NP- a Mice were immunized with 10 µg of NP-CGG in alum and challenged 5-8 weeks later with 10 µg of soluble NP-CGG (see Fig. 1 ). They were sacrificed 4-5 days after the challenge and examined for NP-specific IgG APFC (seven mice). Spleens from two animals were pooled for hybridoma production.
b Proportion of cells containing V H segments with one or more nucleotide substitutions among the total number of analyzed cells. Splenic APFC were obtained from two mice and represent at least 10 distinct V(D)J clonotypes. The BM APFC were isolated from three mice and represent at least six independent clonotypes. The size of V(D)J repertoire is probably an underestimate because these are heavily mutated sequences. In some cases, it was difficult to determine whether the nucleotide differences in CDR3 represent somatic events or junctional diversity.
c Range of mutations among individual V H 186.2 genes. d Replacement/silent mutation ratio. ( Table 2 ). The patterns of recurrent somatic mutations could A transition in the GGCT mutational hot-spot (46,47) in position 26, which replaces Gly with Asp, suggesting an antigen not be assessed because individual analogue V H gene mutants were recovered too infrequently throughout this study, selection process among the V102 ϩ B cells even though the mutation is in FWR2. [A different interpretation is given to with the exception of the V102 gene (Fig. 8) . Seven out of nine V102 sequences from unrelated APFC contained a G → V102 position 10 where we found A instead of G in every sequence, including those that did not contain any other proceed along distinct pathways of repertoire maturation and nucleotide substitution (Fig. 8) . We believe that A in position differentiation. The predominant cell population, which uses 10 represents the correct germline sequence of this gene].
the V H 186.2-DFL16-1/2 rearrangement with the canonical Some of the analogue V H sequences recovered from secTyr95 joint and accumulates somatic mutations including the ondary APFC were unmutated, raising the possibility that the recurrent W33L, apparently migrates from GC to the spleen respective APFC originated from naive B cells in the presence and BM, and differentiates into high-affinity antibody-produof carrier-primed T h cells, rather than from true memory cing cells at later stages of the immune response (42, 48, 49 ). B cells. In order to gain further insight into this problem,
Here we show that somatic diversification of the V186.2/Tyr95/ the repertoire of analogue V H gene-expressing B cells was Leu33 cell lineage is tissue specific. The APFC in BM evolved examined by construction of hybridomas. Mice immunized from highly mutated precursors, whereas the splenic APFC with NP-CGG/alum were boosted 60 days later with soluble did not accumulate mutations above the level seen in the GC antigen and the splenocytes were immortalized at days 4 B cells. The primary GC in the spleen cease by 4-5 weeks after the antigen boost. Several stable, NP-binding hybridoma after the immunization with antigen in alum (42, 45) , but clones were obtained that expressed respectively V H 102, perhaps some B cells continue to mutate in the post-GC CH10 and 23 ( Table 5 ). The binding affinities of these mAb phase of the response (48) . The distinct repertoire of BM were comparable to the affinities of the V186.2 ϩ secondary effector cells could indicate that only the highly mutated B hybridomas and at least 1 log higher than that of the V186.2 ϩ cells home to BM and differentiate in to APFC. Alternatively, mAb B1-8γ1 ( Table 5 ) that is representative of the primary and more likely, the progeny of GC B cells circulate through germline-encoded anti-NP antibody (35) . The fine specificity spleen and BM, and the latter environment provides signal(s) of the secondary analogue mAb is also comparable to that for their continuing somatic mutation and differentiation to of secondary canonical mAb: they bind NP and NIP equally APFC in situ, as has been proposed for human BM (50). Such well, whereas the primary, unmutated V186.2 ϩ antibodies signal(s) could be generated by BM CD3 ϩ CD4 ϩ lymphocytes, show a preferential binding to NIP (Table 5 ) (35) . Although which are unusual in that the majority has a memory/activated the sample is small, it is noticeable that the affinities of the phenotype (51) . Indeed, depletion of CD4 ϩ lymphocytes analogue mAb to NP did not correlate with the extent of 3 weeks after the immunization selectively eliminated the mutation in V H, and that even unmutated mAb may have an highly mutated APFC in BM (Fig. 4) . affinity that is typical of secondary response (cf. the V23 mAb
Although the principal GC B cell lineage, V186.2/Tyr95/ 11-2-9 and 60-2-10 and the VCH10 mAb G6-18-6 and G6-Leu33 , does contain precursor memory cells (14,16), the brisk 18-10 in Table 5) .
anamnestic response to a low-dose, soluble antigen boost is dominated by a different population of effector V186.2 ϩ APFC Discussion that have a distinct N residue Gly95, germline-encoded Trp33 and the K58R replacement. B cell clones with Gly95 have The model of antibody response to NP demonstrates how primary splenic GC spawn multiple B cell populations that rarely been recovered from NP-specific GC (10,18,48) sug- gesting that the V186.2 ϩ /Gly95/Arg58 memory cell subset unmutated. As stated earlier, we cannot rule out that the unmutated APFC were generated from naive rather than undergoes a post-GC expansion and maturation to become a 'higher order of memory' cell (52) in the spleen and BM. memory B cells. However, we were able to obtain secondary hybridomas that used analogue V H genes with few or no Furokawa et al. (53) recently found that the V186.2/Gly95 mAb (Gly99 in their numbering system) reached higher affinitsomatic mutations, which had affinities that are representative of the memory repertoire to NP (Table 5) . We hypothesize that ies than the V186.2/Tyr95 mAb did during the affinity maturation of anti-NP response. Although the authors did not mention V H analogue clones may reach the memory pool without mutation and affinity maturation, consistent with the prediction it, all of their V186.2/Gly95 shared the K58R and none had the W33L, as is the case of APFC in our study. We propose (54) that the germline-encoded affinities of certain BCR are not increased by introduction of somatic mutations. that K58R is a key mutation for selection of the highest affinity memory B cells in the post-GC stage of anti-NP response.
The molecular and functional heterogeneity of memory B cells has been best demonstrated by Berek, Milstein and The third population of NP-reactive GC/memory B cells is composed of diverse clonotypes expressing at least 10 co-workers, in studies of hybridomas from mice that were repeatedly immunized with a hapten, oxazolone (4, 55, 56) . closely related V H analogue genes which, as a group, account for almost half of APFC in the late primary response in the The secondary and tertiary responses were dominated by distinct cell lineages, depending on immunization protocol. spleen and BM, and a variable portion of the anamnestic response. These clonotypes were observed in earlier studies, Berek and Milstein (56) proposed that co-evolution of functionally diverse memory B cell clones is made possible because but their potential was not appreciated. Weiss and Rajewsky (9) recovered a large number of rearranged V H analogue of their compartmentalization, either by antigen presentation, anatomical separation or cell kinetics. The NP-specific memgenes at 6 weeks after immunization with NP-CGG, many of which were said to contain somatic mutations. Others have ory borne by the V H 186.2 clonotypes exemplifies the paradigm of repertoire maturation based on selection of higher-affinity B described NP-binding hybridomas after secondary immunizations which expressed several analogue V H genes (14,23). In cell mutants during the late primary and secondary responses (55,57,58). On the other hand, the behavior of NP-reactive one study (23) , the anamnestic response to NP was initiated with anti-idiotype, which led the authors to postulate that the V H analogue clones is reminiscent of the responses in which the antibody affinities improve little (59) or not at all (60,61) high percentage of NP-binding hybridomas with analogue V H genes resulted from a triggering of naive B cells. A most after the repeated immunization. We propose that the evolution of distinct phenotypes of memory B cells may depend on the convincing demonstration of the existence of analogue V H memory cells was provided by Decker et al. (43) in their initial affinities of the respective BCR for NP and on the signals from T h cells. The latter is suggested by the observations study of secondary and tertiary responses to NP in splenic fragments. Between 20 and 50% of fragments that produced that the expansion of NP-specific V186.2 clones is T celldependent: the analogue V H clonotypes become prevalent the secondary or tertiary anti-NP antibody were occupied by analogue V H gene clonotypes that contained somatic when T cell help is either decimated by advanced age (38) or by-passed altogether by immunization with a T-independent mutations, which were also recovered from APFC in our study, including V593, 24.8, 23 and 165.1. Here we show that the form of NP (13) . We may reasonably postulate that the affinity of BCR influences the concentration of MHC-peptide ligands late primary and secondary APFC expressing analogue V H do not accumulate somatic mutations above the range found on the B cells, which has been shown to influence the quality of T cell help (62, 63 
